Oriana Papin-Zoghbi

Oriana Papin-Zoghbi serves as the Chief Executive Officer and Co-Founder, distinguished for her visionary leadership in the field of women’s health and diagnostics. She has been selected for Bloomberg New Economy Catalysts and will represent the women’s health industry at the Bloomberg New Economy Forum in Singapore. Her contributions to ovarian cancer diagnosis have earned her a spot in Inc’s 2022 Top 100 Female Founders. Papin-Zoghbi’s global experience spans creating and leading organizations to successful strategic exits, managing teams at both early-stage startups and large life sciences companies. She has fostered a highly productive culture, turning visions into tangible outcomes, and has spearheaded market entry strategies and product launches in various new markets. These include launching nationwide HPV screening in East Africa and introducing novel diagnostics in fields such as maternal fetal medicine, oncology, and infectious diseases. Her dedication and impactful work have been recognized with numerous awards, including the Massachusetts Life Sciences Center MassNextGen Award, The Eddies People’s Choice Award, and The Wave Summit’s Emerging Women Founder in Bio Award. Oriana Papin-Zoghbi holds a degree in Economics and International Relations from Boston University.